10:09 AM EDT, 09/11/2019 (MT Newswires) -- Adial Pharmaceuticals (ADIL) said Wednesday that it has successfully retested a previously manufactured supply of clinical trial packaged tablets of the investigational drug AD04 for the treatment of alcohol use disorder.
The company said tests showed that the clinical trial materials passed reevaluation and are eligible for use in the phase 3 trial.
The company has great information about it on their website with promising statisics.
The company said tests showed that the clinical trial materials passed reevaluation and are eligible for use in the phase 3 trial.
The company has great information about it on their website with promising statisics.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.